Dysport (abobotulinumtoxinA), a form of purified botulinum toxin, has received a positive opinion in Europe for managing urinary incontinence…
Articles by Margarida Maia, PhD
Women who were exposed to sexual or emotional abuse as children may be at an increased risk of developing multiple sclerosis…
This year’s Scientific Breakthrough Award, funded by the American Brain Foundation, has been awarded to Stephen Hauser, MD, for…
COVID-19 does not seem to be linked to increased disability worsening or more relapses in the long term for people…
A researcher in Barcelona, Spain, has been chosen to receive the 2022 John Dystel Prize for his work advancing…
PIPE-307, an investigational myelin-restoring medication being developed by Pipeline Therapeutics for the treatment of multiple sclerosis (MS), appears…
Treatment with an autologous hematopoietic stem cell transplant (aHSCT) seems to reboot the immune system in multiple sclerosis (MS)…
This year’s Harry Weaver Neuroscience Scholar Award, funded by the National Multiple Sclerosis (MS) Society, has gone to a…
Tevogen Bio is planning to make use of its virus-fighting immune cell technology and turn it against Epstein-Barr virus…
Tecfidera (dimethyl fumarate) appears to have similar benefits to Gilenya (fingolimod) in preventing relapses and the loss of…
Long-term treatment with Gilenya (fingolimod) in routine clinical practice is safe and effective for relapsing-remitting multiple sclerosis (RRMS),…
Cognition-targeting exercise, when combined with cognitive behavioral therapy (CBT) — a type of talk therapy — may further ease fatigue…
Donations to the Multiple Sclerosis Society of Canada through the end of this year will be double matched, meaning…
People with a higher genetic risk for multiple sclerosis (MS) are significantly more likely to develop the disease at…
Cortrophin Gel (repository corticotropin injection), an injectable gel medication approved for acute flares in multiple sclerosis (MS) and…
Sensorimotor exercise, which aims to improve the neuromuscular system with reduced pressure interventions, such as robotic-assisted training or aquatic exercises,…
Taking the hormone melatonin may increase overall sleep quality in people with multiple sclerosis (MS), a clinical trial found.
Mynd Diagnostics is launching a clinical study to test the ability of a blood biomarker, which the company coined Mynd…
Side effects upon receiving the COVID-19 vaccine in people with multiple sclerosis (MS) are similar to those reported in the…
Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS)…
Owlytics Healthcare, in partnership with Tel-Aviv Medical Center in Israel, has taken its smartwatch — designed to monitor symptoms…
Australia’s National Health and Medical Research Council (NHMRC) is giving a total of AU$6.75 million (about $5 million) in…
People with multiple sclerosis (MS) are not at greater risk for severe COVID-19 outcomes, according to a study of…
A six-week program, called vibration training — in which people stand on a vibrating platform for short periods of time…
The National Multiple Sclerosis Society will host the second edition of its Black MS Experience Summit, a…
Sativex (nabiximols), a cannabis-based oral spray approved in the U.K. to ease spasticity — or muscle stiffness and…
People who develop multiple sclerosis (MS) in childhood have more difficulty recognizing words and faces than healthy individuals, a…
Skin reactions are common among relapsing-remitting multiple sclerosis (RRMS) patients being treated with oral Mavenclad (cladribine), affecting about one-third…
Blacks with multiple sclerosis (MS) have more severe disease and greater disability at their first visit than white patients,…
Alan Thompson, dean of the Faculty of Brain Sciences at University College London (UCL), has won the 2021Â Charcot Award,…